Title : Antagonism of sorafenib and regorafenib actions by platelet factors in hepatocellular carcinoma cell lines.

Pub. Date : 2014 May 21

PMID : 24885890






2 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 The aims were to evaluate whether hPL can modulate the actions of sorafenib or regorafenib, two clinical HCC multikinase antagonists. regorafenib galectin 1 Homo sapiens
2 RESULTS: Both sorafenib and regorafenib-mediated inhibition of cell growth, migration and invasion were all antagonized by hPL. regorafenib galectin 1 Homo sapiens